SAN MATEO, Calif.–(BUSINESS WIRE)–Evidation, the leader in direct-from-participant real-world data and health research, today announced the completion of participant monitoring and biospecimen collection in its Precision in Autoimmune Condition Evidence (PACE) pilot, advancing a new approach to understanding the biology of autoimmune disease as it changes over time. PACE is the first study of its kind in rheumatoid arthritis to combine fully decentralized, symptom-triggered blood collection a
